Q4 Follow-Up - Pharmarise HDS (2796 JP) - September 2, 2025

240 Views25 Sep 2025 20:05

Issuer-paid

SUMMARY

In Q4 of FY2025/5, Pharmarise Holdings Corporation (hereafter, the Company) consolidated the performance of next PH Corporation (hereafter, next PH), driving a 22% year-on-year increase in net sales and a turnaround to operating profit for the full fiscal year.
At GOOD AID Co., Ltd.(hereafter, GOOD AID), whose shares were acquired in January 2024, post-merger integration (PMI) has progressed following the resignation of the former management team and the replacement of pharmacists, and signs of a recovery in performance have begun to emerge.
In Q4, the operating profit margin improved to 1.2%, though it remains low.

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream